Abstract 11271: Post TAVR Outcomes Among Patient With Amyloidosis and Aortic Stenosis: A Meta Analysis

IntroductionAortic stenosis (AS) is one of the most prevalent valvular heart diseases globally. As many as 16% of AS patients have underlying cardiac amyloidosis (CA). To date, there is a paucity of data on outcomes among AS with concomitant CA patients post-TAVR. HypothesisThis study aimed to evalu...

Full description

Saved in:
Bibliographic Details
Published in:Circulation (New York, N.Y.) N.Y.), 2022-11, Vol.146 (Suppl_1), p.A11271-A11271
Main Authors: Jaiswal, Vikash, Ang, Song Peng, Kalra, Kriti, Khan, Nida, Joshi, Amey, Jaiswal, Akash, Vadiyala, Mounika Reddy, Patel, Nirmit, Chia, Jia Ee, Raut, Anuradha, Aziz, Taiba, Manohar, Hasitha
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:IntroductionAortic stenosis (AS) is one of the most prevalent valvular heart diseases globally. As many as 16% of AS patients have underlying cardiac amyloidosis (CA). To date, there is a paucity of data on outcomes among AS with concomitant CA patients post-TAVR. HypothesisThis study aimed to evaluate the clinical outcomes post TAVR among patients with CA. MethodsWe performed a systematic literature search of databases for relevant articles from inception until June 01, 2022. Unadjusted odds ratios (OR) were pooled using a random-effect model, and a p-value of
ISSN:0009-7322
1524-4539
DOI:10.1161/circ.146.suppl_1.11271